Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
18.36
+0.23 (+1.30%)
Streaming Delayed Price
Updated: 3:21 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
August 21, 2024
Via
Benzinga
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier.
Via
Investor's Business Daily
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
August 13, 2024
Via
Benzinga
The 7 Best Under $20 Stocks to Buy in August 2024
August 07, 2024
Although cheap stocks are often cheap for a reason, it doesn't hold true for the best stocks under $20, which is where investors can profit.
Via
InvestorPlace
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
August 02, 2024
Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours.
Via
InvestorPlace
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
July 31, 2024
Via
Benzinga
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
July 19, 2024
Via
Benzinga
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
July 31, 2024
Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript
July 31, 2024
TEVA earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views
June 27, 2024
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
June 12, 2024
Via
Benzinga
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
May 30, 2024
Via
Benzinga
Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales
July 31, 2024
Teva Pharmaceutical reported Q2 2024 sales of $4.16 billion, surpassing the $4.06 billion consensus. Revenue rose 7% YoY, driven by growth in generic products and Austedo sales. Adjusted EPS was $0.61,...
Via
Benzinga
Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise
July 31, 2024
The company now expects $16 billion to $16.4 billion in full-year sales.
Via
Investor's Business Daily
Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
July 31, 2024
Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know
May 22, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2024
Via
Benzinga
Why Hims & Hers Heath Shares Are Surging Today
July 22, 2024
Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appointment to the Board of Directors.
Via
Benzinga
Teva's Migraine Treatment Found Effective For Children As Young As 6
July 18, 2024
Teva Pharmaceutical's Phase 3 SPACE study reveals Ajovy's significant efficacy in preventing episodic migraines in children aged 6-17. The trial's primary endpoint was met with safety data aligning...
Via
Benzinga
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde.
Via
Benzinga
3 No-Brainer Stocks to Buy With $200 Right Now
July 17, 2024
A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.
Via
The Motley Fool
Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
July 16, 2024
Via
Benzinga
FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse
July 01, 2024
The FTC is investigating Teva Pharmaceuticals for alleged misuse of inhaler patents to block generic competition and maintain high prices in the U.S. while selling the same products for less overseas.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Dr. Reddy's Labs Stock Sees Improved Technical Strength
June 28, 2024
On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76.
Via
Investor's Business Daily
Teva Engages In Settlement Talks Over Medicare Kickback Allegations
June 18, 2024
Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copaxone sales, risking up to $10 billion in damages.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know
June 14, 2024
Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceuticals Inc. (NYSE: TEVA) has sued the company, accusing it of a monopoly...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.
Via
InvestorPlace
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.